RET and medullary thyroid gland carcinoma: As shown in Fig. 3A,B, proliferation of RET-positive MTC (TT and MZ-CRC-1), PTC (TPC-1) and NSCLC (Lc-2/ad) cells started to be affected already at 0.2 nM Pz-1.